CardlyticsvsIntel

CDLX and INTC stock compared: price, dividend, valuation and results, from SEC filings.

CDLX

Cardlytics, Inc.

$1.34

Value $8.2M

-6.29%
CDLX's page

INTC

Intel Corporation

$59.66

Value $317B

-2.52%
INTC's page

Cardlytics (CDLX) has a market value of $8.2M and Intel (INTC) $317B. Over the last year, with dividends, CDLX moved -91.1% and INTC +57.5%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CDLX$8.2M

    INTC$317B

    INTC is 38,784 times CDLX

  • Revenue, 12 months

    CDLX$176M

    INTC$59.9B

    INTC is 340 times CDLX

  • Net income, 12 months

    CDLX-$37M

    INTC-$12.0B

  • Operating margin

    CDLX-19.2%

    INTC2.9%

    22.1 points apart

  • ROIC

    CDLX-11.8%

    INTC0.9%

    12.6 points apart

  • P/E

    CDLX–

    INTC–

  • Dividend yield

    CDLX0.0%

    INTC0.0%

    About the same

  • 5-year return

    CDLX-99.9%

    INTC+27.9%

    127.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CDLX-99.9%

INTC+27.9%

010020030020222023202420252026
Returns by period
PeriodCDLXWith dividendsINTCWith dividends
1 year since November 12, 2025-91.1%Price -91.1%+57.5%Price +57.5%
3 years since November 13, 2023-98.2%-73.7% a yearPrice -98.2%+58.2%+16.5% a yearPrice +56.1%
5 years since November 12, 2021-99.9%-72.9% a yearPrice -99.9%+27.9%+5.0% a yearPrice +18.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CDLXCardlyticsINTCIntel

Valuation

CDLXINTC
Valuation
Price$1.34$59.66
Market value$8.2M$317B
Enterprise value (EV)$173M$313B
P/E––
P/E, 5-year median––
P/B–2.8
EV/EBIT–177.8
Free cash flow yield–1.2%

Results and growth

CDLXINTC
Results and growth
Revenue, 12 months$176M$59.9B
Net income, 12 months-$37M-$12.0B
Free cash flow, 12 months-$7.2M$3.8B
Earnings per share, 12 months-$19.50-$2.42
Revenue growth, year on year-16.2%-0.5%
Revenue growth a year, past+4.5%over 5 years-7.5%over 5 years
EPS growth a year, past––

Margins and returns on capital

CDLXINTC
Margins and returns on capital
Gross margin–39.9%
Operating margin-19.2%2.9%
Net margin-20.8%-20.1%
ROIC-11.8%0.9%
ROE–-11.3%

Balance sheet

CDLXINTC
Balance sheet
Cash$30M$54.0B
Total debt$200M$50.1B
Net debt / EBITDA–-0.3
Interest cover–1.5×

Dividends and buybacks

CDLXINTC
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months––
Dividend growth a year, past––
Buyback yield––
Shareholder yield––

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CDLX or INTC

Didn't find what you were looking for?

Ask us
Which is bigger, Cardlytics or Intel?

By market value, Intel ($317B) is about 38,784.2 times Cardlytics ($8.2M), at today's prices.

How did CDLX and INTC stock do over the last 5 years?

Since November 12, 2021, CDLX's price moved -99.9% and INTC's +18.6%. With dividends: CDLX -99.9% (-72.9% a year), INTC +27.9% (+5.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, CDLX or INTC?

Neither paid a dividend over the last twelve months: Cardlytics and Intel return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Cardlytics or Intel?

Over the last twelve months, the net margin was -20.8% for Cardlytics and -20.1% for Intel, and the operating margin -19.2% and 2.9%. Revenue was $176M and $59.9B.

Which is the better investment, Cardlytics or Intel?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.